Total Payments
$1,251
2024 Payments
$17.67
Companies
16
Transactions
70
Medicare Patients
1,041
Medicare Billing
$90,322
Payment Breakdown by Category
Food & Beverage$1,247 (99.7%)
Education$3.85 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,247 | 69 | 99.7% |
| Education | $3.85 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $777.64 | 47 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.65 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $72.52 | 4 | $0 (2023) |
| Novo Nordisk Inc | $70.06 | 4 | $0 (2020) |
| Lilly USA, LLC | $39.53 | 2 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $27.33 | 2 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $25.66 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $24.42 | 1 | $0 (2019) |
| Hikma Pharmaceuticals USA | $22.89 | 1 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $21.14 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.67 | 1 | Ferring Pharmaceuticals Inc. ($17.67) |
| 2023 | $19.62 | 1 | Gilead Sciences, Inc. ($19.62) |
| 2021 | $148.63 | 10 | AbbVie Inc. ($136.07) |
| 2020 | $335.99 | 20 | AbbVie Inc. ($212.17) |
| 2019 | $292.76 | 14 | AbbVie, Inc. ($234.22) |
| 2018 | $230.32 | 16 | AbbVie, Inc. ($142.34) |
| 2017 | $205.81 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($76.65) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug), REBYOTA | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.62 | General |
| 11/22/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: VIROLOGY | ||||||
| 09/02/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: VIROLOGY | ||||||
| 07/30/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: VIROLOGY | ||||||
| 06/18/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: VIROLOGY | ||||||
| 04/15/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: VIROLOGY | ||||||
| 03/11/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/08/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $12.56 | General |
| Category: Cardiovascular | ||||||
| 01/29/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/22/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: VIROLOGY | ||||||
| 01/11/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/15/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/15/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/23/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.40 | General |
| 11/13/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VIROLOGY | ||||||
| 10/21/2020 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $20.01 | General |
| 10/13/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VIROLOGY | ||||||
| 10/09/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/22/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VIROLOGY | ||||||
| 09/15/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.48 | General |
| 09/11/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/04/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
| 07/22/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 167 | 333 | $42,453 | $15,293 |
| 2021 | 8 | 328 | 555 | $54,717 | $26,318 |
| 2020 | 12 | 546 | 1,634 | $114,111 | $48,711 |
Total Patients
1,041
Total Services
2,522
Medicare Billing
$90,322
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 129 | $21,433 | $8,148 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 56 | $12,874 | $4,122 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,627 | $1,428 | 54.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 38 | $3,591 | $1,122 | 31.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 38 | $1,038 | $369.66 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 26 | $200.06 | $59.28 | 29.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 15 | 35 | $690.00 | $44.38 | 6.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 165 | $19,470 | $9,663 | 49.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $9,724 | $5,888 | 60.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 77 | 135 | $11,175 | $5,311 | 47.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 49 | $9,955 | $4,617 | 46.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 29 | 61 | $2,293 | $482.95 | 21.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 17 | 20 | $730.00 | $195.95 | 26.8% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 15 | 25 | $250.00 | $98.25 | 39.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 25 | 56 | $1,120 | $61.55 | 5.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 183 | 672 | $67,200 | $34,886 | 51.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 68 | 126 | $8,190 | $3,842 | 46.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 52 | $7,540 | $3,826 | 50.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 64 | 224 | $9,184 | $2,274 | 24.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 30 | 30 | $4,380 | $2,006 | 45.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 11 | 12 | $6,072 | $572.27 | 9.4% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 20 | 21 | $735.00 | $402.57 | 54.8% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 19 | 25 | $875.00 | $327.67 | 37.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 18 | $360.00 | $298.26 | 82.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 36 | 175 | $3,500 | $261.36 | 7.5% |
About Dr. Kozhimala John, MD
Dr. Kozhimala John, MD is a Gastroenterology healthcare provider based in Zephyrhills, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891890638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kozhimala John, MD has received a total of $1,251 in payments from pharmaceutical and medical device companies, with $17.67 received in 2024. These payments were reported across 70 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,247).
As a Medicare-enrolled provider, John has provided services to 1,041 Medicare beneficiaries, totaling 2,522 services with total Medicare billing of $90,322. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine
- Location Zephyrhills, FL
- Active Since 09/14/2006
- Last Updated 05/10/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1891890638
Products in Payments
- Mavyret (Drug) $213.03
- MAVYRET (Drug) $153.03
- LINZESS (Drug) $118.29
- CREON (Drug) $91.45
- Creon (Drug) $79.53
- JARDIANCE (Drug) $76.65
- Ozempic (Drug) $53.16
- EMGALITY (Drug) $39.53
- Livalo (Drug) $27.33
- XIFAXAN (Drug) $25.66
- AIMOVIG (Biological) $24.42
- Mitigare (Drug) $22.89
- BREATHTEK (Device) $21.14
- Viekira (Drug) $19.70
- CLENPIQ (Drug) $17.67
- Albutein (Biological) $17.31
- JANUVIA (Drug) $12.21
- LINX Reflux Management System (Device) $11.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Zephyrhills
Tawfik Chami, Md, MD
Gastroenterology — Payments: $27,028
Gastroenterology $27,028
Mark Eisner, Md, MD
Gastroenterology — Payments: $16,592
Gastroenterology $16,592
Dr. Soloman Singh, Md, MD
Gastroenterology — Payments: $12,908
Gastroenterology $12,908
Dr. Yawer Nensey, Md, MD
Gastroenterology — Payments: $9,602
Gastroenterology $9,602
Maher Salam, M.d, M.D
Gastroenterology — Payments: $4,778
Gastroenterology $4,778
Dr. Thomas John, Md, MD
Gastroenterology — Payments: $2,506
Gastroenterology $2,506